Luteal phase support with GnRH agonist does not eliminate the risk for ovarian hyperstimulation syndrome

Shevach Friedler, Leonti Grin

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

This study aims to report a case of early, severe ovarian hyperstimulation syndrome (OHSS) following GnRH agonist trigger for final oocyte maturation despite luteal support with a GnRH agonist. Contrary to the claim that luteal support using a GnRH agonist eliminates the risk for OHSS in high-risk patients, this report alerts practitioners to the risk of severe OHSS development despite GnRH agonist luteal support in patients receiving GnRH antagonist protocol with GnRH agonist triggering and cautions the practitioners to consider other measures of OHSS prevention.

Original languageEnglish
Pages (from-to)368-369
Number of pages2
JournalGynecological Endocrinology
Volume35
Issue number5
DOIs
StatePublished - 4 May 2019

Keywords

  • GnRH agonist
  • GnRH agonist trigger
  • GnRH antagonist
  • OHSS
  • luteal support

Fingerprint

Dive into the research topics of 'Luteal phase support with GnRH agonist does not eliminate the risk for ovarian hyperstimulation syndrome'. Together they form a unique fingerprint.

Cite this